Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

9.1%

1 terminated out of 11 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

55%

6 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results86% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (2)
P 2 (1)
P 3 (5)
P 4 (1)

Trial Status

Completed6
Unknown3
Terminated1
Withdrawn1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (11)

Research Network

Activity Timeline